Fortis FY26: Double-Digit Profit Growth in Q4

New Delhi, May 22 (PTI) Healthcare major Fortis group has registered a high double-digit profit growth in the last quarter of the financial year ending March 31, 2026, vis-a-vis the figures in the corresponding quarter in FY 2025.

The firm on Friday announced its audited consolidated financial results for the quarter of FY 2026, and said the year ended for the group on a "healthy note".

For the last quarter (Q4), consolidated revenues stood at Rs 2,365 cr, up 17.8 per cent, year-on-year (YoY), according to a statement issued by Fortis Healthcare.

Profit After Tax was at Rs 271 cr, up 44.2 per cent from Q4 figures for the financial year ending on March 31, 2025, it said

For FY 2026, the consolidated revenues stood at Rs 9,128 cr, up 17.3 per cent year-on-year, according to the data shared in the statement issued by the healthcare behemoth.


"The increase in debt compared to March 31, 2025 was primarily due to the acquisition of the People Tree Hospital in Yeshwanthpur, Bengaluru and Shrimann Hospital in Jalandhar, Punjab, amongst other investments," the statement said.

Revenue growth in the hospital business was driven by a 15 per cent increase in occupied beds in FY26 compared to FY25 and a 17 per cent increase in occupied beds in Q4 FY26 compared to Q4 FY25, it added.

"Key procedure volumes performed across certain focus specialties such as radiation therapy and robotic surgeries increased by 19 per cent and 66 per cent YoY for the year," the firm said.

"Key high value medical equipment added during the year included five soft tissue surgical robots, two MRI machines, four cath labs, one PET CT, etc." it added.

Dr Ashutosh Raghuvanshi, CEO, Fortis Healthcare said, "We have witnessed a steady business performance in Q4 enabling us to end the year on a healthy note."

"Our hospital business which now contributes 85 per cent to our overall revenues, continues to do well. We have maintained our investment momentum in augmenting medical equipment and technology, adding to our clinical depth and expanding key medical programmes," he was quoted as saying in the statement.